HopeStage
Back to all studies
RecruitingNCT02844049

Deep brain stimulation or medical treatment for resistant OCD

About this titleRead the official source — NCT02844049
Device studyAges 18–69Multiple countries
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 69 years.

Listed locations
Créteil and 7 more locationsSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: September 2016
Recruitment status
Recruiting
Enrollment listed in the registry
60
Sponsor
University Hospital, Grenoble
Sponsor type
Hospital / academic medical center
Study type
Device
Intervention type
Device
Locations
France, Switzerland, Germany, ...
Age range
From 18 Years to 69 Years
Official registry ID
NCT02844049
Official title
Show the full official title

European Study of Quality of Life in Resistant OCD Patients Treated by STN DBS Versus Best Medical Treatment

Recruitment & locations

Currently recruiting

Créteil, France · Grenoble, France · Nice, France

4 more locations
  • Paris, France
  • Cologne, Germany
  • Stockholm, Sweden
  • Geneva, Switzerland

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University Hospital, Grenoble, a hospital or academic medical center.

Who can participate?

Listed age limits: 18 years to 69 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies